Osaic Holdings
DMAC icon

Osaic Holdings’s DiaMedica Therapeutics DMAC Stock Holding History

Osaic Holdings’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.38M Buy
338,107
+18,432
+6% +$113K ﹤0.01% 2165
2026
Q1 		$2.16M Buy
319,675
+72,703
+29% +$576K ﹤0.01% 2007
2025
Q4 		$1.97M Buy
246,972
+64,667
+35% +$484K ﹤0.01% 2110
2025
Q3 		$1.25M Buy
182,305
+38,015
+26% +$206K ﹤0.01% 2585
2025
Q2 		$563K Buy
144,290
+113,893
+375% +$444K ﹤0.01% 3025
2025
Q1 		$115K Buy
30,397
+29,342
+2,781% +$168K ﹤0.01% 4071
2024
Q4 		$5.73K Hold
1,055
– – ﹤0.01% 6116
2024
Q3 		$4.42K Sell
1,055
-1,000
-49% -$3.69K ﹤0.01% 6268
2024
Q2 		$6.06K Buy
2,055
+1,055
+106% +$2.9K ﹤0.01% 6077
2024
Q1 		$2.77K Hold
1,000
– – ﹤0.01% 6344
2023
Q4 		$2.84K Hold
1,000
– – ﹤0.01% 6392
2023
Q3 		$2.58K Buy
1,000
+999
+99,900% +$3.21K ﹤0.01% 6535
2023
Q2 		$4 Buy
+1
New +$2 ﹤0.01% 7431

Other funds holding DMAC

CLG
Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Osaic Holdings's DMAC Position: Q2 2026 in Review

Osaic Holdings increased its DiaMedica Therapeutics (DMAC) stake by 5.8% in Q2 2026, buying an estimated $113K and bringing the position to 338,107 shares worth $2.38M. The position accounts for ﹤0.01% of the portfolio, ranked #2165.

Osaic Holdings first reported a position in DMAC in Q2 2023 and has held it in 13 quarters since. 89 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

  • Osaic Holdings held 338,107 shares of DiaMedica Therapeutics worth $2.38M as of Q2 2026.
  • Osaic Holdings bought 18,432 DiaMedica Therapeutics shares in Q2 2026, an estimated $113K.
  • DiaMedica Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #2165 holding.
  • Osaic Holdings first reported a position in DiaMedica Therapeutics in Q2 2023 and has held it in 13 quarters since.
  • 89 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.